FDA Inspection 1079952 — Atlanta Blood Services

Atlanta Blood Services — FEI 3001739811

The FDA completed an inspection of Atlanta Blood Services on February 6, 2019 in Atlanta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 6, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Atlanta, GA (United States)